|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Myovant Sciences Ltd [MYOV]
$12.43 0.41 (3.19%)
Market Cap 910 Million
Myovant Sciences Ltd is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its product candidate is relugolix, which is an oral, once-daily, gonadotropin-releasing hormone (GnRH) receptor antagonist.
EPS -1.04 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Pay Date --
This list of trending stocks may change throughout the trading day.